Lilie Lin, MD, FASTRO

Dr. Lilie Lin is a Professor at the University of Texas, MD Anderson Cancer Center where her clinical and research focus is on gynecologic malignancies. She has been extensively involved in developing and implementing clinical and translational research protocols for patients with gynecologic and breast cancers. She is the PI of multiple investigator initiated therapeutic studies combining novel agents with radiotherapy in both the definitive as well as the metastatic/recurrent setting. Additionally, her research program is focused on identifying imaging (Magnetic Resonance Imaging(MRI)/Positron Emission Tomography (PET)) and tissue biomarkers of toxicity and poor response to therapy. She has an active interest in global health and building capacity in clinical research. Her research has been funded by the NCI, DOD, and multiple philanthropic foundations.

Disclosures:

• Employment: The University of Texas MD Anderson Cancer Center:Professor:Employee;VA Hospital:physician:Employee
• Compensation: Trevarx: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: present ;NCI: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: present ;Pfizer: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: present ;Astrazeneca: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: present ;Varian: Research Grants, Research Funding, Research Salary Support,
• Ownership: none
• Leadership: none